Absci (ABSI) Change in Accured Expenses (2020 - 2025)

Absci's (ABSI) quarterly Change in Accured Expenses came in at $2.5 million in Q3 2025, up 80.22% year-on-year from $1.4 million in Q3 2024, and up 22.87% quarter-over-quarter from $2.0 million in Q2 2025.

Absci (ABSI) Change in Accured Expenses (2020 - 2025) Analysis & Trends

Absci has disclosed Change in Accured Expenses across 6 years of filings, most recently posting $2.5 million for Q3 2025.

  • Change in Accured Expenses for Q3 2025 came in at $2.5 million, up 80.22% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.9 million (up 233.87% YoY), and the FY2024 annual result was -$295000.0, up 75.68% from the prior year.
  • Change in Accured Expenses came in at $2.5 million for Q3 2025 at Absci, up from $2.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.9 million in Q3 2022 to a low of -$4.5 million in Q1 2022.
  • The 5-year median for Change in Accured Expenses is -$374000.0 (2023), against an average of -$77947.4.
  • Across the five-year window, Change in Accured Expenses slumped 1337.23% in 2021 and soared 437.49% in 2022, its largest moves.
  • Absci's Change in Accured Expenses stood at $2.1 million in 2021, then slumped by 123.28% to -$500000.0 in 2022, then climbed by 25.2% to -$374000.0 in 2023, then jumped by 303.21% to $760000.0 in 2024, then surged by 230.79% to $2.5 million in 2025.
  • The last three Change in Accured Expenses figures came in at $2.5 million (Q3 2025), $2.0 million (Q2 2025), and -$3.4 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 931,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Absci 1.13 Bn 1.01 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 2.51 Mn
Sep 30, 2025 2.51 Mn
Jun 30, 2025 2.05 Mn
Jun 30, 2025 2.05 Mn
Mar 31, 2025 -3.41 Mn
Mar 31, 2025 -3.41 Mn
Dec 31, 2024 760,000.00
Dec 31, 2024 760,000.00
Sep 30, 2024 1.40 Mn
Sep 30, 2024 1.40 Mn
Jun 30, 2024 1.46 Mn
Jun 30, 2024 1.46 Mn
Mar 31, 2024 -3.91 Mn
Mar 31, 2024 -3.91 Mn
Dec 31, 2023 -374,000.00
Dec 31, 2023 -374,000.00
Sep 30, 2023 2.96 Mn
Sep 30, 2023 2.96 Mn
Jun 30, 2023 -1.38 Mn
Jun 30, 2023 -1.38 Mn